These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17705153)

  • 1. On the volume of distribution at steady state and its relationship with two-compartmental models.
    Yates JW; Arundel PA
    J Pharm Sci; 2008 Jan; 97(1):111-22. PubMed ID: 17705153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the accuracy of estimation of basic pharmacokinetic parameters by the traditional noncompartmental equations and the prediction of the steady-state volume of distribution in obese patients based upon data derived from normal subjects.
    Berezhkovskiy LM
    J Pharm Sci; 2011 Jun; 100(6):2482-97. PubMed ID: 21254063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.
    Wu X; Nekka F; Li J
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):447-59. PubMed ID: 27405818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mathematical comparison between volume of distribution (V) and volume of distribution at steady-state (Vss) utilizing model-independent approach.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2004 Mar; 25(2):99-101. PubMed ID: 14872558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the accuracy of calculation of the mean residence time of drug in the body and its volumes of distribution based on the assumption of central elimination.
    Berezhkovskiy LM
    Xenobiotica; 2016; 46(6):477-82. PubMed ID: 26406808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical analysis of the discrepancy between V(beta) and V(ss) for drugs exhibiting different two-compartment disposition profiles.
    Sobol E; Bialer M
    Biopharm Drug Dispos; 2005 Mar; 26(2):51-8. PubMed ID: 15614832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume of distribution at steady state for a linear pharmacokinetic system with peripheral elimination.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Jun; 93(6):1628-40. PubMed ID: 15124219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the possibility of the secondary peaks of iv bolus drug plasma concentration time curve by the model that directly takes into account the transit time through the organ.
    Berezhkovskiy LM
    J Pharm Sci; 2009 Nov; 98(11):4376-90. PubMed ID: 19340884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative performance of different stochastic methods to simulate drug exposure and variability in a population.
    Tam VH; Kabbara S
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):185-8. PubMed ID: 16930922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the determination of the time delay in reaching the steady state drug concentration in the organ compared to plasma.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Dec; 96(12):3432-43. PubMed ID: 17628491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of volume of distribution at steady state with complete consideration of the kinetics of protein and tissue binding in linear pharmacokinetics.
    Berezhkovskiy LM
    J Pharm Sci; 2004 Feb; 93(2):364-74. PubMed ID: 14705193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of trimethoprim in the rat.
    Tu YH; Allen LV; Fiorica VM; Albers DD
    J Pharm Sci; 1989 Jul; 78(7):556-60. PubMed ID: 2778654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calculation of steady-state distribution delay between central and peripheral compartments in two-compartment models with infusion regimen.
    Wu G
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):259-64. PubMed ID: 12587955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties of indinavir in rat: some limitations of noncompartmental analysis.
    Hamidi M
    Drug Dev Ind Pharm; 2010 Mar; 36(3):355-61. PubMed ID: 19722914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
    De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
    Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the accuracy of a one-compartment approach for determination of drug terminal half-life.
    Berezhkovskiy LM
    J Pharm Sci; 2013 Jul; 102(7):2082-4. PubMed ID: 23620272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.